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Abstract
Background: Alzheimer’s disease (AD) is a neurodegenerative disorder primarily characterized by the deposition of b-
amyloid plaques in the brain. Plaques are composed of the amyloid-b peptide derived from cleavage of the amyloid
precursor protein (APP). Mutations in APP lead to the development of Familial Alzheimer’s Disease (FAD), however, the
normal function of this protein has proven elusive. The organism Caenorhabditis elegans is an attractive model as the
amyloid precursor-like protein (APL-1) is the single ortholog of APP, and loss of apl-1 leads to a severe molting defect and
early larval lethality.
Methodology/Principal Findings: We report here that lethality and molting can be rescued by full length APL-1, C-terminal
mutations as well as a C-terminal truncation, suggesting that the extracellular region of the protein is essential for viability.
RNAi knock-down of apl-1 followed by drug testing on the acetylcholinesterase inhibitor aldicarb showed that loss of apl-1
leads to aldicarb hypersensitivity, indicating a defect in synaptic function. The aldicarb hypersensitivity can be rescued by
full length APL-1 in a dose dependent fashion. At the cellular level, kinesins UNC-104/KIF-1A and UNC-116/kinesin-1 are
positive regulators of APL-1 expression in the neurons. Knock-down of the small GTPase rab-5 also leads to a dramatic
decrease in the amount of apl-1 expression in neurons, suggesting that trafficking from the plasma membrane to the early
endosome is important for apl-1 function. Loss of function of a different small GTPase, UNC-108, on the contrary, leads to
the retention of APL-1 in the cell body.
Conclusions/Significance: Our results reveal novel insights into the intracellular trafficking of APL-1 and we report a
functional role for APL-1 in synaptic transmission.
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Introduction
Alzheimer’s disease (AD) is a progressive neurodegenerative
disorder characterized by the deposition of b-amyloid plaques, loss
of cholinergic neurons and accumulation of neurofibrillary tangles
within the brain. Plaques are primarily composed of the amyloid-b
peptide derived from cleavage of the amyloid precursor protein
(APP). Despite the discovery of dominant mutations in APP that
lead to the development of Familial Alzheimer’s Disease, the
normal functional role of this protein within the neuron is still
unclear. Past studies have implicated APP in cell adhesion,
synaptogenesis, cell migration, signaling, apoptosis, axonal trans-
port as well as development of the neuromuscular junction
suggesting that APP is not restricted to a single function (See [1]
for review).
APP is a type I trans-membrane protein that is conserved from
C. elegans to humans. APP knock-out mice are viable and fertile
and have mild defects in locomotor activity, forelimb grip strength,
behavior and long term potentiation (LTP) [2,3,4,5]. The subtlety
of these phenotypes is thought to be due to functional redundancy
with the two other members of the APP family, APLP1 and
APLP2 as loss of APLP2 along with one of the other two APP
homologs results in early postnatal lethality in mice [6,7]. Because
of the redundancy of these homologs, using the mammalian
system to study the function of APP has proven challenging.
The C. elegans model offers a simplification of the mammalian
system in that APL-1 is the only APP ortholog in the nematode
and a null mutation leads to early larval lethality [8]. APL-1 is
structurally similar to its mammalian counterpart and shares three
major regions of homology: the N-terminal E1 and E2 domains
and the highly conserved intracellular C-terminal domain [9].
APL-1 does not contain the amyloid-b sequence, similar to the
functionally redundant mammalian APP homologs APLP1 and
APLP2 [10,11,12].
In this study, we use C. elegans to investigate the normal
functional role of APL-1. We report that APL-1 is necessary for
viability, molting and regulation of neurotransmission. Full length
rescue of the synaptic transmission defect is dose dependent, while
the N-terminus of APL-1 is sufficient to rescue the molting and
lethality phenotypes. At the cellular level, proper localization and
protein levels of APL-1 throughout the neuron are dependent on
the kinesin transporters UNC-104/KIF1A and UNC-116/kinesin-
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indicating their likely role in APL-1 vesicle transport and
endocytosis.
Materials and Methods
C. elegans Strains
Strains were cultivated at 20u as described previously [13]. The
strains used in this study include the wild-type Bristol N2 strain,
apl-1(tm385)/lon-2(e678), lon-2(e678), dgk-1(nu62), unc-32(e189),
unc-49(e372), rrf-3(pk1426), unc-104(e1265), unc-116(e2310), unc-
108(n3263). Crosses were performed using standard genetics
methods and final strains identified by phenotype and PCR.
RNAi
RNAi was performed by feeding as previously described [14].
RNAi clones were isolated from the Ahringer RNAi library (Gene
Service) by streaking clones onto plates containing 10 mg/ml
tetracycline and 100 mg/ml ampicillin. Before use, all RNAi clones
isolated from the library were validated by sequencing. Cultures
were grown overnight in LB containing 100 mg/ml ampicillin and
used to seed NGM plates containing 1 mM IPTG and 50 mg/ml
ampicillin.
Development and Brood Size Assays
Ten to twelve young adult worms were placed on individual
RNAi plates or NGM plates and allowed to lay eggs overnight.
The eggs were collected onto new plates and counted. After
48 hours the worms were scored for their developmental stage.
For brood size assays, ten L4 worms were placed on individual
NGM plates. Every 24 hours the number of eggs the worms
produced were counted and the mothers transferred to new plates
until no more eggs were produced. Brood size assays were
analyzed by one-way ANOVA with Bonferroni post-hoc test.
Movement Assays
Body bends per minute were obtained by placing late L4 worms
individually on NGM plates and screening 24 hrs later. Body
bends were counted over a 3 min time period and then divided to
calculate the average number of body bends in one minute. One
body bend is completed when the point behind the pharynx
reaches the opposite apex of the sinusoidal curve. Measurements
were statistically analyzed by one-way ANOVA with Bonferroni
post-hoc test.
Plasmid Construction
All constructs were generated, unless otherwise described, by
amplifying target sequences with Phusion High-Fidelity DNA
Polymerase (Finnzymes) using primers with overhanging restric-
tion sites. The PCR products were digested with their respective
restriction enzymes and ligated to the destination vector backbone.
For apl-1 expression studies and rescue experiments, worm apl-1
genomic coding DNA was amplified from cosmid C42D8 (Sanger
Institute) including 4.4 kb of sequence upstream from the start
codon. This fragment was ligated into L3781 (Addgene plasmid
1590; Fire Lab C. elegans Vector Kit, 1999 plate) in frame with the
GFP sequence at the C-terminal end of apl-1 to generate papl-
1::apl-1::gfp. The C-terminal truncation construct papl-1::apl-
1DIC::gfp was generated by amplifying the coding region of apl-1
excluding the sequence for the last 36 amino acids. This PCR
product was cloned into L3781 followed by cloning the apl-1
promoter upstream. Constructs containing papl-1::apl-1DYENP-
TY::gfp, papl-1::apl-1::T658A::gfp, and papl-1::T658E::gfp were
generated from the original papl-1::apl-1::gfp full length construct
using site-directed mutagenesis to introduce the individual
mutations. For human rescue studies, human APP cDNA
containing an mRFP fusion was amplified from N1-APP-RFP
and cloned into the L3781 expression vector that had been cut
with XmaI and NheI to remove the coding region of GFP. The
apl-1 promoter was amplified from C42D8 then added to the
APP::RFP clone to generate papl-1::APP::RFP. APLP1 and
APLP2 cDNA sequences were amplified from clones 3865417
and 2820109 (Open Biosystems) respectively and also cloned into
the L3781 vector with the GFP tag on the 39 end of the gene
followed by the insertion of the apl-1 promoter.
Plasmids for colocalization purposes were made by amplifying
mCherry from the vector pCFJ90 (Addgene plasmid 19327; [15])
and cloning the sequence upstream of the start codon of either rab-
5 or unc-108 cDNA. For rab-5, the mCherry sequence was cloned
into pBZ103 containing phsp16/2::rab-5 followed by cloning the
apl-1 promoter to generate the final construct containing papl-
1::mCherry::rab-5. The unc-108 construct was developed by
inserting the amplified mCherry sequence into pAOLO174
containing punc-108::unc-108(Q65L). The Q65L mutation was
removed using site-directed mutagenesis to generate the WT
sequence. pBZ103 and pAOLO174 were generous donations from
the Zhou lab at Baylor College of Medicine.
All constructs were completely sequenced to verify accuracy of
promoters and coding regions. All primers used for cloning are
referenced in File S1.
Transgenic Strains
Transgenic strains were generated through microinjection of
DNA constructs into the worm gonad as previously described [16].
For expression studies, papl-1::apl-1::gfp (40 ng/ml) was co-injected
with the marker construct pRF4 (75 ng/ml), which contains rol-
6(su1006). The rescue constructs described above were individu-
ally injected into the gonads of the apl-1(tm385)/lon-2(e678) strain.
F1 progeny containing the array were individually cloned onto
new plates and the F2 progeny of the lines were analyzed to
determine if rescue of the L1 lethality occurred by absence of both
long worms, indicating loss of the balancer, and arrested L1
progeny. Presence of the tm385 deletion was tested by PCR. The
full length apl-1 10 ng/ml expressing strain was integrated by UV
irradiation, outcrossed 3X with the lon-2(e678) strain to maintain
the tm385 deletion then crossed to the rrf-3(pk1426) background
for RNAi studies. For colocalization experiments, constructs were
co-injected into N2 worms. Rescue strain construct concentrations
are listed in Table 1 with each being co-injected with the pmyo-
3::CFP marker (L4816; Fire Lab C. elegans Vector Kit, 1999 plate)
(20 ng/ml) and pCR2.1 added to a final injection concentration of
100 ng/ml. For colocalization experiments the following injection
concentrations were used: papl-1::apl-1::gfp (20 ng/ml), papl-
1::mCherry::rab-5 (20 ng/ml), punc-108::mCherry::unc-108 (5
ng/ml); pRF4 (75 ng/ml). Strains created in this study are listed
in File S1. Representative strains are listed where multiple strains
were generated at the same concentration.
Aldicarb Assay
L4 hermaphrodites were placed on control (L4440) or apl-1
RNAi plates and allowed to mature and lay eggs overnight. Young
adults from the F1 progeny were placed onto NGM plates
containing 1 mM aldicarb (PS734, Sigma-Aldrich) in the presence
of food then scored semi-blind for response to a harsh touch every
10 minutes for 2 hours. Animals unable to respond to the touch
were scored as paralyzed. Adult RNAi aldicarb experiments were
performed 48 hrs after young adult animals were placed on the
control (L4440) or apl-1 RNAi plates. All rescue and mutant strains
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one-way ANOVA with Bonferroni post-hoc test.
Protein Extraction and Western Blotting
Worms were synchronized by bleaching as previously described
[17] and three 10 cm plates containing L4 stage worms were
harvested.SampleswerewashedwithTE,pelletedbycentrifugation
then placed at 280uC for at least 15 min. The pellet was thawed
and all liquid replaced with 50 ml RIPA buffer containing protease
inhibitors (Roche). Samples were sonicated twice for 10 seconds
each then centrifuged at 10,5006g for 10 min at 4uC. Supernatants
were collected and protein concentrations were measured by plate
reader using a detergent-compatible colorimetric protein assay (Bio-
Rad). Samples were then combined with 2X loading buffer and
boiled at 80uC for 10 min prior to loading. SDS-PAGE was
performed by loading 20 mg of protein sample into a 5% SDS-
polyacrylamide gel. Samples were transferred onto nitrocellulose
membrane and then the membrane was blocked for 2 hrs in 5%
milk diluted with PBST. Membranes were probed with antibodies
against GFP 1:5000 (ab290; Abcam) or C. elegans c-tubulin 1:1000
(ab50721;Abcam) overnight in blocking solution. Following incu-
bation with primary antibodies, membranes were washed 3X for
10 min in PBST, incubated with 2u anti-Rabbit HRP-conjugated
antibody 1:5000 (Vector Laboratories) for 1 hr then washed again
3X for 10 min in PBST. Bands were detected using the Amersham
ECL chemiluminescence reagent (GE Healthcare Life Sciences)
and band density quantified using ImageJ software (National
Institutes of Health). Band density was normalized to the loading
control and compared using the Student’s t-test.
Fluorescence Microscopy and Quantification
Imaging was performed by placing live animals anesthetized
with 20 mM sodium azide on a 2% agarose pad. Images were
obtained using a Zeiss Axioscope 2 Plus upright microscope
equipped with an Axiocam MRm camera and Axiovision 4.1
software. Pictures were acquired with 100X or 63X lens. In the
case of fluorescence quantification, head neurons of 10–20 worms
per genotype were imaged with identical exposure times. Each
neuronal cell body was imaged at its widest diameter in the plane
of focus. Fluorescence was quantified using ImageJ. Control
pictures were taken on the same day to account for differences in
bulb intensity. Genotypes were compared using the Student’s t-
test. Colocalization experiments were performed by taking images
on an Olympus IX50 inverted microscope. Images underwent de-
convolution using Metamorph software and then overlayed using
ImageJ. Colocalization quantification was performed as previously
described [18] using intensity correlation analysis with the
following modifications. The neuronal cell body was set as the
region of interest and then the intensity correlation quotient (ICQ)
was quantified using ImageJ as described by the McMaster
Biophotonics Facility. In brief, an ICQ of 0 indicates random
staining between the two fluorescent images while 0,ICQ#0.5
indicates colocalization and 0$ICQ.20.5 occurs during segre-
gated staining. For further description of the analysis refer to Li
et al. (2004) [18]. ICQ values of the neurons were statistically
analyzed using the one-sample t-test to compare the mean ICQ
values against a random staining value of 0.
RNA Extraction and qRT-PCR
Worms were synchronized by bleaching and harvested at the L4
stage (,6,000 per sample) by rinsing worms off the plate using TE.
Samples underwent a freeze/thaw cycle 4X between liquid nitrogen
and a 37uC waterbath followed RNA isolation using the Qiagen
RNeasy Lipid Tissue kit method withthe addition of the RNase free
DNase steps (Qiagen). cDNA was generated by reverse transcrip-
tion using the Superscript III First Strand kit (Invitrogen) with the
input of equal concentrations (1000 ng/ml) of RNA as measured by
NanoDrop (NanoDrop Technologies). PCR primers to test apl-1
expression were designed using Primer Express 2.0 (Applied
Biosystems) (apl-1 Fwd ACTCACAGTGTCAGACCGTACCA,
apl-1 Rev GTGCGGGACTTGAAGAGCTT) and ama-1 was used
as the endogenous control (ama-1 qPCR f1 CACGCGTT-
CAGTTTGGAATTC, ama-1 qPCR r1, AACTCGACATGAGC-
CACTGACA). Dilutions of the cDNA samples were mixed with
SYBR Green following the Power SYBR Green PCR Master Mix
protocol (Applied Biosystems). Quantitative real-time PCR (qRT-
PCR) was performed using the ABIprism 7000 and data collected
using the 7000 System SDS Software (Applied Biosystems). Primer
efficiencies were originally validated using the standard curve
method with all subsequent experiments using a 1:50 dilution of
cDNA and results analyzed using the comparative Ct method. Bars
represent the mean of a triplicate containing a single biological
sample with error bars calculated from the sample and endogenous
control standard deviations (STD = !((Sample STD)‘2+(House-
keeping Gene STD)‘2)).
Results
Characterization of apl-1 Expression
To determine the expression pattern of apl-1, transgenic worms
were generated expressing an apl-1::gfp fusion protein driven by the
endogenous apl-1 promoter. APL-1::GFP fluorescence is detected in
the cell bodies and processes of nerve ring interneurons (Figure 1
A,e)and the ventralcord (Figure 1 A,g). apl-1::gfp is alsoexpressed in
Table 1. Summary of injection constructs and their rescue of
apl-1(tm385) lethality.
Constructs
a Concentration
Rescue/Total
Strains
papl-1
b::apl-1::gfp 20 ng/ml4 / 4
10 ng/ml4 / 4
papl-1::apl-1 20 ng/ml3 / 3
10 ng/ml3 / 3
5 ng/ml3 / 3
papl-1::apl-1DIC::gfp 20 ng/ml0 / 3
10 ng/ml8 / 8
papl-1::apl-1 T658A::gfp 20 ng/ml8 / 8
papl-1::apl-1 T658E::gfp 20 ng/ml3 / 3
papl-1::apl-1DYENPTY::gfp 20 ng/ml4 / 4
10 ng/ml7 / 7
papl-1::APP::RFP 40 ng/ml0 / 3
20 ng/ml0 / 2
10 ng/ml0 / 3
papl-1::APLP1::gfp 20 ng/ml0 / 2
10 ng/ml0 / 3
papl-1::APLP2::gfp 20 ng/ml0 / 2
10 ng/ml0 / 2
papl-1::APP::RFP; papl-1::
APLP1::gfp; papl-1::APLP2::gfp
20 ng/ml each 0/3
aConstructs were used to inject apl-1(tm385)/lon-2(e678) and the F2 progeny
were examined for the generation of a rescue strain.
bEndogenous apl-1 promoter.
doi:10.1371/journal.pone.0012790.t001
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seen in junctional cells such as the pharyngeal intestinal valve
(Figure 1 A,e), which tethers the pharynx to the intestine, and the
uterine seam junction in adults (Figure 1 A,h), which provides the
structural connection between the epidermis and the uterus. APL-1
can be weakly detected in many epidermal epithelia including hyp7
(Figure 1 A,f), the hypodermal syncitium surrounding the worm, as
well as vulval cells, rectal valve cells, pharyngeal arcade cells, and
tail hypodermis. Expression is prominent in the excretory cell
(Figure 1 A,h), a long H-shaped cell implicated in fluid balance.
APL-1 was notably absent from body wall muscle and intestine.
These expression patterns indicate that apl-1 is active in cells with
high levels of structural components such as synapses, junctional
epithelial cells and cells with apical basal polarity.
apl-1 Loss of Function and Genetic Rescue
Similar to the molting defect caused by apl-1 null mutations,
knock-down of apl-1 using RNAi on the RNAi sensitive rrf-
3(pk1426) strain led to defective molting starting at the L3/L4 molt
and continuing in the L4/YA molt (Figure 1B). A variety of
molting phenotypes were seen which ranged from loose cuticle
around the head and tail (7.5%, n=173), internal pinching of the
worm body at or just posterior to the head (4.6%), degradation
around the mouth area (9.8%) or a cuticle plug around the mouth
(38.1%) (Figure S1A, B). All of the worms had a very transparent
appearance that, when examined at higher magnification,
appeared as empty spaces in the worm spanning the length of
the body. apl-1 knock-down also led to delayed development, as
most of the population after two days was in the L4 stage while the
majority of the control worms had completed development to
adulthood (Figure S1C). Furthermore, we observed that worms on
apl-1 RNAi exhibited sluggish movement, failing to move normally
even when touched.
The apl-1(tm385) allele is a deletion that removes 646 base pairs
including exon 3, which deletes 42 amino acids leading to a frame
shift of the downstream sequence, resulting in a premature stop
Figure 1. Characterization of apl-1 expression and loss of function. (A(a–d)) DIC images corresponding with APL-1::GFP fluorescence (A(e–h))
respectively. vpi – pharyngeal intestinal valve; VC – ventral cord; exc- excretory cell; utse – uterine seam junction (Scale bar, 10 mm) (B) N2 L4 worm on
control RNAi bacteria (L4440) (a), L4 worm with partial gene knock-down using apl-1 RNAi showing loose cuticle in the head (b) and tail (c) region.
(Scale bars, 20 mm) (C) N2 worm at L1 (a) compared to an apl-1(tm385) homozygous L1 arrest demonstrating degradation in the head (b) and tail (c).
(Scale bar, 10 mm) (D) Rescue of the molting phenotype of the apl-1 homozygous null worms by apl-1::gfp at L1 (a) and L4 stages (b). (Scale bars
10 mm and 20 mm respectively)
doi:10.1371/journal.pone.0012790.g001
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deletion are L1 lethal and exhibit internal vacuolization,
degradation and loose cuticle phenotypes (Figure 1C) similar to
previously reported null mutations [8], indicating that the tm385
lesion is also null. We attempted to rescue the lethality of this
mutant using constructs containing either full length apl-1,
mutations within the highly conserved C-terminal domain, a C-
terminal truncation of apl-1, or human APP, APLP1 or APLP2
(summarized in Table 1). All constructs were driven by the apl-1
promoter and fused to a C-terminal GFP. Rescue constructs
included a deletion of the highly conserved YENPTY motif which
is known to bind to many different adaptor proteins or mutations
of the conserved Thr668 residue (Thr658 in APL-1) which is a
phosphorylation site that can regulate the localization and binding
partners of APP [19,20,21,22,23]. The Thr658 site was mutated
either to Ala (T658A) or Glu (T658E) to mimic the dephosphor-
ylated and constitutively phosphorylated protein respectively. In
addition, we created a C-terminal truncation construct (DIC) by
removing the last 36 amino acids of the protein leaving the trans-
membrane sequences intact rather than expressing only the
soluble ectodomain of APL-1, attempting to maintain proper
membrane anchoring and correct processing of the protein. To
avoid any potential complications associated with the C-terminal
GFP fusion used to monitor APL-1 expression, we also performed
rescue experiments in parallel using full-length apl-1 lacking the
GFP tag.
Previous genetic rescue studies showed that the full length APL-
1, the N-terminal sequences of APL-1, as well as the non-
overlapping E1 or E2 fragments of APL-1 were sufficient to rescue
apl-1 null lethality [8]. These strains were generated by injecting
very high concentrations of the DNA constructs (50–100 ng/ml),
which consequently led to strong over-expression of apl-1 and
functional impairments including delayed development, sluggish
movement and smaller brood sizes. This ectopic over-expression
may bypass any intracellular trafficking or processing requirement
needed for rescue under physiological conditions. We attempted to
limit these potential over-expression side effects by injecting much
lower concentrations of the expression vectors (ranging from 10–
20 ng/ml). We found that the most highly expressing array on the
N2 background displayed normal movement and brood sizes with
only a slight developmental delay (Figure S2), indicating that the
effect of over-expression is minimal at the DNA concentrations we
used for injection.
When expressed on the apl-1(tm385) background, we found that
full length apl-1 along with all of the C-terminal mutation
constructs were able to rescue the lethality and molting defects
caused by the tm385 deletion (Figure 1D, Table 1). Interestingly,
while injection of apl-1 DIC at 10 ng/ml rescued the lethality and
molting, the construct was unable to rescue at the higher
concentration of 20 ng/ml. The reason for this dose-dependent
rescue is not clear as it is not seen in any of the other constructs.
In order to determine if human APP or one of its mammalian
homologs APLP1 or APLP2 could act as functional homologs to
apl-1, each of these genes expressed by the apl-1 promoter were
injected individually into apl-1(tm385) heterozygous worms to test
for rescue of the apl-1 lethality. Similar to the previous report of
APP being unable to rescue apl-1 null lethality [8], none of the
human genes were able to rescue the tm385 lethality, either
expressed separately or together (Table 1).
apl-1 Deficiency Leads to Aldicarb Hypersensitivity
Independent of the Molting Phenotype
Mammalian studies have revealed that mice lacking both APP
and APLP2 display impaired synaptic structure and function at the
peripheral cholinergic neuromuscular junction [24]. To examine
whether apl-1 knock-down has a similar effect on neurotransmis-
sion, worms were tested for their response to the acetylcholines-
terase inhibitor aldicarb, which blocks the breakdown of
acetylcholine in the synaptic cleft, leading to constant stimulation
of postsynaptic receptors and paralysis over time [13,25]. Worm
mutants with excess or depleted acetylcholine become hypersen-
sitive or resistant to aldicarb respectively. We found that apl-1
RNAi treated worms exhibited hypersensitivity to aldicarb
(Figure 2A, B). In order to address the question of whether this
phenotype may be a secondary effect due to the molting defect also
seen in these worms, we bypassed the molting stages by placing
RNAi sensitive young adult worms that have completed the molt
cycle on apl-1 RNAi and subjected them to aldicarb testing. These
worms were also hypersensitive to aldicarb (Figure 2C, D),
indicating a direct effect of APL-1 on neurotransmission,
independent of molting.
Next, we examined whether the transgenically expressing full
length APL-1 rescue strains were able to rescue this neurotrans-
mission defect. We tested full length strains made by injecting
different concentrations of DNA (20 ng/ml and 10 ng/ml), and
therefore having different levels of transgenic protein expression
confirmed by both qRT-PCR and Western blot (Figure 3A, S4A).
Interestingly, only the strain that expressed the higher concentra-
tion of APL-1 was able to rescue the aldicarb hypersensitive
phenotype while the lower expressing strain did not (Figure 3B, C).
These results show a dosage dependent effect of APL-1. This effect
was not due to the presence of the GFP tag, as rescue strains with a
similar level of expression without the tag retained the aldicarb
hypersensitivity (Figure S3). Since the rescue of aldicarb
hypersensitivity, but not molting or development, by full length
APL-1 is dose dependent, this result further strengthens the notion
that APL-1 directly mediates synaptic transmission independent of
molting.
To test whether the C-terminus of apl-1 is required for the
regulation of neurotransmission, we tested the aldicarb sensitivity
of the DIC and the DYENPTY rescue strains and found that the
C-terminal mutants exhibited similar aldicarb hypersensitivity as
compared to full length APL-1 expressed at comparable levels
(Figure S4). These data provide indirect support against a potent
role of the highly conserved C-terminal domain in APL-1
mediated synaptic transmission.
UNC-104/KIF1A, UNC-116/Kinesin 1 and RAB-5 Positively
Regulate APL-1 Expression
While the trafficking of APP has been extensively studied in
neurons, the movement of APL-1 through the cell is still unknown.
APP is normally trafficked in a kinesin-dependent anterograde
fashion from the cell body to the nerve terminal [26]. Due to APL-
1’s strong expression in neurons, we decided to test whether APL-1
can be transported by two of the major kinesins involved in
anterograde transport of synaptic proteins. The first kinesin we
investigated is the worm homolog of KIF1A, UNC-104. UNC-
104/KIF1A is responsible for transporting synaptic vesicles and
dense core vesicles to sites of synaptic transmission [27,28,29]. In
order to test if APL-1 transport depends on this neuronal kinesin,
we crossed the APL-1::GFP transgenic rescue strain to the
hypomorphic mutant unc-104(e1265). Interestingly, rather than
observing an accumulation of the GFP fluorescence in the cell
body, which traditionally results from the reduction of UNC-104
mediated vesicle transport [27], we found a dramatic decrease in
the fluorescence from apl-1::gfp on the unc-104(e1265) background,
as measured by fluorescence intensity in a set of three head inter-
neurons that consistently expressed apl-1 (Figure 4A, B) Addition-
APL-1 Function in C. elegans
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neurons, quantified from a specific dorsal process that is
consistently visible on the N2 background (Figure 4C). Western
blotting from L4 worms also detects a drop in APL-1 protein
expression on the unc-104(e1265) background (Figure 4D, E).
qRT-PCR comparing apl-1 expression between N2 and unc-
104(e1265) backgrounds showed no differences, suggesting that the
loss of APL-1::GFP is occurring at the protein level (Figure 4F).
Figure 3. Rescue of aldicarb hypersensitivity by apl-1 is dose dependent. (A) qRT-PCR showing representative rescue strain expression of
apl-1 at different injection concentrations. Error bars represent the STD. (B) Aldicarb hypersensitivity is not rescued by apl-1 full length at a lower
expression level. Strains expressing half the level of the original full length strain can no longer rescue the aldicarb hypersensitivity, but rather show a
dosage dependent effect. Two rescue strains per genotype were used to rule out variability from over-expression of the rescue array (representative
strains shown). Control: unc-49 - GABA receptor subunit, aldicarb hypersensitive. (C) Quantification of the rescue strain aldicarb experiment at 90
minutes. (*, P,0.05) Error bars represent the s.e.m. unless otherwise noted.
doi:10.1371/journal.pone.0012790.g003
Figure 2. Aldicarb hypersensitivity from loss of apl-1. (A) Aldicarb sensitivity over time from worms exposed to apl-1 RNAi throughout
development. apl-1 knock-down leads to aldicarb hypersensitivity. Controls: dgk-1 - diacylglycerol kinase mutant, aldicarb hypersensitive; unc-32 -
mutant for a vacuolar H
+-ATPase, aldicarb resistant. (B) Quantification at the 90 minute time point. (C) To avoid the molting defect, adult worms were
placed on apl-1 RNAi, which also led to the same aldicarb hypersensitivity. (D) Quantification of the adult RNAi aldicarb experiment at 90 minutes.
Each experiment was performed at least three times (n=50 per strain). (**, P,0.01; ***, P,0.001) All error bars represent the s.e.m.
doi:10.1371/journal.pone.0012790.g002
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kinesin-1 to transport APL-1 by crossing the APL-1::GFP
transgenic strain to the hypomorphic unc-116(e2310) background.
Kinesin-1 has been found to play a prominent role in the transport
of APP along the axon [26]. Again we saw a reduction in the
amount of APL-1::GFP expression on the unc-116 mutant
background, although to a lesser extent as that on the unc-104
background (Figure S5). However, there was a complete loss of
APL-1 expression along the dorsal axon in every nematode
analyzed on the unc-116 background. These results suggest that
APL-1 localization is dependent on both kinesins.
In addition to being transported by kinesins, APP has previously
been shown to localize to the early endosome by its strong
colocalization with Rab5 positive compartments in preparations of
nerve terminals from rat forebrain and PC12 cells [30,31]. As a
small GTPase, Rab5 regulates endosomal trafficking of vesicles
from the plasma membrane to the early endosome [32]. To
determine whether APL-1 was also present in RAB-5 compart-
ments in the worm we generated strains co-expressing APL-
1::GFP and mCherry::RAB-5. We found that these proteins
colocalized within a subset of puncta (Figure 5A). This was
reconfirmed by observing consistently positive intensity correlation
quotient (ICQ) values in the different neurons analyzed (Figure 5B).
To determine whether loss of rab-5 had an effect on the
localization of APL-1, we used RNAi to knock-down rab-5
expression in an integrated APL-1::GFP expression strain on the
RNAi sensitive rrf-3(pk1426) background. Loss of rab-5 led to a
dramatic decrease in the amount of APL-1::GFP in neurons as
well as a complete loss of APL-1 in the dorsal process (Figure 5C,
D). By contrast, knock-down of two other small GTPases, rab-7 or
rab-10, did not affect APL-1 expression, suggesting that RAB-5
compartments specifically are important for the localization of
APL-1 (Figure 5E).
unc-108 Mutations Lead to Altered Intracellular
Localization of APL-1
UNC-108 is a small GTPase expressed in neurons and engulfing
cells that localizes to the Golgi and early endosome [33,34]. UNC-
108 has been found to be involved in the maturation of dense core
vesicles (DCVs), a distinct vesicular population containing peptide
hormones and neuropeptides [34,35,36]. APL-1 likely undergoes
fast axonal transport in a vesicular population, therefore we
wanted to investigate if UNC-108 is required for the packaging of
APL-1 into vesicles destined for anterograde transport.
To study this possibility we crossed the hypomorphic mutant
unc-108(n3263) to the APL-1::GFP expressing strain. We found
that one of the head inter-neurons appeared to have a back-up of
protein in the cell body (Figure 6A, B). This aggregation of protein
in a distinct compartment was also seen in ventral cord neurons.
We then performed colocalization experiments by generating
strains expressing APL-1::GFP and mCherry::UNC-108. Similar
to the colocalization with RAB-5, APL-1 is found in overlapping
puncta with UNC-108 in neurons, demonstrating APL-1 locali-
zation to the same compartment (Figure 6C). The ICQ values of
the different neuronal populations were consistently positive,
showing that the proteins colocalize together at a similar frequency
as with RAB-5 (Figure 6D). These data suggest that UNC-108 is
required for the localization of APL-1 and ultimately its transport.
Discussion
N-terminus of APL-1 Is Required for Worm Survival and
Molting
We have shown that loss of apl-1 contributes to defects in at least
two systems, one of which is molting. The L1 lethality seen in the
apl-1(tm385) strain is likely due, at least in part, to the molting
defect, which is recapitulated by apl-1 RNAi. Worms with apl-1
Figure 4. Loss of the neuronal kinesin unc-104 leads to a decrease of APL-1 expression. (A) Representative pictures of head interneurons
expressing apl-1::gfp on N2 and unc-104 backgrounds. Neurons are arbitrarily labeled A, P and C for Anterior, Posterior and Central respectively. (Scale
bar, 2.5 mm) (B) Quantification of APL-1::GFP fluorescence in the cell bodies of the corresponding head neurons (n=20 per strain). (C) Percent of
dorsal cord processes derived from a single head neuron visible in the N2 and unc-104 backgrounds (N2=10, unc-104=15). (D) Western blot showing
diminished APL-1 protein levels in the kinesin mutant. Two lines per genotype were used for analysis. (E) Quantification of Western blot. (F) qRT-PCR
data showing unchanged transcription levels of apl-1 between the N2 and unc-104 mutant. Error bars represent the STD. (*, P,0.05; **, P,0.01;
***, P,0.001) Error bars represent the s.e.m. unless otherwise noted.
doi:10.1371/journal.pone.0012790.g004
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phenotypes of apl-1(tm385) L1s but exhibit these phenotypes later
in development. The clear appearance of these worms may be due
to inappropriate release of proteases involved in the molting
process, loss of proper adhesion between tissues, and/or loss of fat
stores due to starvation from the loose cuticle blocking food intake.
Whether the sluggish movement defect seen in adult apl-1 knock-
down worms is due to the molting defect, starvation or a
neurotransmission defect remains to be seen. The phenotypes
shown in this RNAi study are more severe than those described
previously [37], possibly due to our use of an RNAi sensitive strain
to ensure neuronal knock-down of apl-1.
The particular molting defect seen with apl-1 RNAi is indicative
of a failure to undergo ecdysis, or shedding of the old exoskeleton
[38]. Another single-pass trans-membrane protein possessing a
similar loose cuticle molting defect is the LDL receptor-related
protein (LRP-1), which is the C. elegans ortholog of LRP-2/megalin
and likely functions in cholesterol uptake and homeostasis
[38,39,40]. A null mutation in LRP-1, like APL-1, leads to arrest
and lethality although at later larval stages [40]. These similarities
suggest that lrp-1 and apl-1 may operate in the same or similar
pathways to control the molting process. Since we found that APL-
1 does not require its C-terminal domain for rescue of the molting
defect and soluble, secreted APP has been shown to bind to an
LRP homolog [41], an attractive hypothesis would be that the N-
terminal domain of APL-1 is shed and released at regulated
periods followed by binding to LRP-1 to mediate proper ecdysis at
each of the four molts.
Our rescue results and previous studies support the notion that
only the N-terminus of APL-1 is required to rescue the lethality
seen in the apl-1 null strain [8]. In mice, expression of APP that has
been truncated either at the a-cleavage site or had the last 15
amino acids removed could ameliorate APP knock-out phenotypes
such as reduced body and brain weight, defective LTP and spatial
learning, and loss of grip strength [42]. These findings combined
support an important function of the N-terminus of APP in the
mammalian system as well as in C. elegans.
While the behavior defects in the Drosophila APPL null can be
rescued byexpression of humanAPP[43],we wereunableto rescue
the apl-1 null lethality in C. elegans by expressing any of the human
homologs of APP. Several notable differences between the fly and
the worm homolog of APP could account for the differences in cross
species rescue. Unlike APL-1, expression of the fly homolog is
confined to neurons and loss of APPL does not affect Drosophila
viability or fertility [43,44]. Furthermore, different domains in APL-
1 and APPL are required for their respective functions. The entire
APPL protein is required for its proper function in the fly, whereas
in C. elegans the APL-1 N-terminus is the critical domain needed to
rescue the lethal apl-1 null mutant. APPL over-expression induced
synaptic bouton formation could be prevented by deletion of the C-
terminal domain or the N-terminal E1 and E2 domains, showing
that the holoprotein is needed to mediate this function [45]. That
APP with a C-terminal truncation expressed in APPL deficient fly
lines could no longer induce axonal arborization seen when
expressing full length APP further highlights the importance of
the C-terminus for proper function of the protein in flies [46]. Since
APL-1 function requires the N-terminus, it is not surprising that the
C. elegans system cannot use APP with its minimally conserved N-
Figure 5. Knock-down of the early endosomal small GTPase
rab-5 leads to a loss of APL-1::GFP. (A) Colocalization of APL-1::GFP
and mCherry::RAB-5. Arrowheads highlight regions of most intense
overlap. (Scale bar, 2.5 mm) (B) Colocalization analysis showing positive
colocalization between APL-1 and UNC-108 in all neuronal populations
examined. Values depicted are an index of the association of staining
intensities of the two fluorophores known as the intensity correlation
quotient. Positive values indicate colocalization while a value of zero
indicates random staining. Values were compared statistically to zero
(random staining). (C) Representative pictures depicting the cell bodies
of the head neurons of apl-1::gfp expressing worms either on control
bacteria (L4440) or rab-5 RNAi. (Scale bar, 2.5 mm) (D) Quantification of
APL-1::GFP fluorescence in the neuronal cell bodies of worms on L4440
or rab-5 RNAi (n=10). (E) Quantification of APL-1::GFP fluorescence on
control, rab-7 and rab-10 RNAi (n=10). No difference in fluorescence
intensity was seen during rab-7 or rab-10 knock-down. (*, P,0.05;
**, P,0.01; ***, P,0.001) Error bars represent the s.e.m.
doi:10.1371/journal.pone.0012790.g005
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phenotypes.
Loss of apl-1 Leads to Neurotransmission Defects
C. elegans and mice share many homologs that are involved in
synaptic structure and function. Therefore we predicted that C.
elegans would be an excellent model to study the importance of
APL-1 in neurotransmission. In mice, APP/APLP2 null animals
have enhanced nerve sprouting, reduced numbers of synaptic
vesicles, defects in neurotransmitter release as well as a large
number of defective synapses [24]. Similar to the mammalian
system, we reveal here that loss of apl-1 expression leads to
defective neurotransmission. We did not observe any overt defect
in general neuronal structure in apl-1(tm385) lethal L1s, therefore
defects in the development of the neuronal network are not likely
to contribute to the phenotype. Interestingly, we would predict
that the defect on aldicarb would be resistance rather than
hypersensitivity if the worms lacking APL-1 also have a reduction
in synaptic vesicle number and decreased number of functional
synapses. These differences may be due to the fact that the
mammalian system uses purely cholinergic connections at the
neuromuscular junction while worm movement is modulated by
both GABAergic and cholinergic synapses. Aldicarb cannot
distinguish between cholinergic or GABAergic defects, nor can
we rule out contributions from dense core vesicles, which also
modulate neurotransmission [47,48,49]. The hypersensitivity we
see during apl-1 knock-down may be due to defects in some or all
of these systems. Future studies will address whether the number
and/or internal structure of the synapses in each of these systems
are affected by loss of apl-1. However, we predict that defects
found in synaptic number or structure, if any, will be subtle due to
the lack of profound locomotor defects during apl-1 knock-down or
in the apl-1 loss-of-function mutant.
Another prospective pathway APL-1 may use to mediate
synaptic transmission is the well studied EGL-30 G-protein
coupled receptor pathway, which can modulate cholinergic
signaling. Loss-of-function mutations in negative regulators of this
Gqa pathway including goa-1/Goa, eat-16/RGS7 and dgk-1, all
lead to a hypersensitive phenotype on aldicarb [50]. In addition,
APL-1 and APP share a conserved Go protein binding domain on
its C-terminus [8,51]. While the C-terminus of APL-1 may not be
required for performing proper molting, we cannot rule out an
important role for this domain in neurotransmission since we
could not create a strain that rescues the aldicarb hypersensitivity
with the DIC construct. Also, the dosage dependent effect we see
with full length APL-1 may be due to improper regulation of this
pathway due to varying levels of interaction with Go. The fact that
loss of apl-1 also leads to enhanced pharyngeal pumping [52]
supports a regulatory role through the EGL-30 pathway as
pharyngeal pumping is one of the many functions modulated by
this G-protein [53].
We have found that the regulation of neurotransmission by
APL-1 does not appear to be related to its regulation of molting. A
molting defect was not seen in any of the rescue strains, or
purposely avoided by performing apl-1 RNAi knock-down in
adults, whereas the aldicarb hypersensitivity was present in these
worms. This dual regulation could not be dissected by removing
the C-terminal domain or YENPTY motif, since the full length
APL-1 rescue of lethality at a lower expression level still could not
rescue the aldicarb hypersensitivity. Together, these data support a
model in which the function of APL-1 in molting is independent of
its function in neurotransmission.
Figure 6. UNC-108 regulates APL-1 localization. (A) Representative pictures of the back-up of APL-1::GFP in the cell body of the central
interneuron in the hypomorphic unc-108(n3263) mutant. (Scale bar, 2.5 mm) (B) Quantification of APL-1::GFP fluorescence in N2 and unc-108(n3263)
neuronal cell bodies (n=10). (C) Colocalization of APL-1::GFP with mCherry::UNC-108. Arrowheads point to overlapping puncta. (Scale bar, 2.5 mm) (D)
Colocalization analysis showing a positive colocalization intensity correlation quotient under every neuronal population quantified. (**, P,0.01;
***, P,0.001) Error bars represent the s.e.m.
doi:10.1371/journal.pone.0012790.g006
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We have found that localization of APL-1 in neurons is
regulated through the action of the kinesins UNC-104/KIF1A and
UNC-116/kinesin-1 as well as the small GTPases RAB-5 and
UNC-108/Rab2 (Figure 7). In mice, APP undergoes fast axonal
transport to the nerve terminal through the action of the kinesin-1
transporter [26]. However, in worms, APL-1 localization is
dependent on both UNC-104/KIF1A and UNC-116/Kinesin-1.
Rather than causing a back-up of protein, loss of either of these
kinesins led to a general loss of APL-1::GFP. This indicates that
the protein is being broken down rather than being allowed to
accumulate in the cell body. Neither of these hypomorphic
mutants have a molting defect, possibly through compensation of
APL-1 trafficking by the other transporter, or the decrease in
function of the kinesin is not severe enough to prevent APL-1 from
operating in the molting pathway.
After being exposed to the cell surface, APP is rapidly
internalized and sorted to the early endosome by the action of
the small GTPase Rab5 [31]. Like APP, we have found that APL-
1 movement through the endosomal pathway utilizes RAB-5 as
loss of RAB-5 reduces the level of APL-1 within the neuron. With
the loss of RAB-5 through RNAi, we speculate that APL-1
becomes trapped on the cell surface where it is subject to increased
exposure to proteases on the plasma membrane, which may
account for the diffusion of GFP signal.
UNC-108/Rab2 is known for its role in COPI-mediated
retrograde transport between the Golgi and ER [54]. However, in
C. elegans, loss of unc-108 does not affect COPI transport, but rather
leads to an accumulation of early endosomal compartments [55].
UNC-108 is also involved in the maturation of dense core vesicles
by preventing loss of cargo to specific endosomal compartments
[34,36]. We suspect that APL-1 accumulation in unc-108(n3263)
mutants may be due to incorrect sorting of APL-1 into the proper
vesicular population upstream of anterograde transport. It is still
unknown whether APL-1 is present in dense core vesicles, although
this subset of vesicles is primarily transported by UNC-104 [56],
which also appears to be the transporter most involved in proper
localization and expression levels of APL-1 (Figure 4). Since the
localization of APL-1 is dependent upon the presence of functional
UNC-108, and the two proteins colocalize, it is possible that APL-1
may play a role either within the DCVs, or actively operating with
UNC-108 in the maturation of DCVs. This may be another
plausible explanation for the ability of APL-1 to regulate synaptic
transmissionasdensecorevesiclecargoshavebeenfoundcapable of
modulating cholinergic signaling [49].
In summary, our results show that APL-1 regulates neurotrans-
mission independently of its function in the molting process. APL-
1 moves through the neuron in a similar fashion to APP, with the
distinction that two kinesins are needed for anterograde transport
and to maintain proper expression levels of APL-1. Like APP, this
transport is followed by endocytosis through the action of RAB-5.
The ability of UNC-108 to alter the localization of APL-1 points to
a novel process by which APL-1 is regulated in the cell. Overall,
we predict that transport of APL-1 within the neuron enables
APL-1 to properly perform its multiple functions by introducing
the protein to molecules that can cleave and regulate release of the
critically important N-terminal portion of the protein. This has
implications for the biology of APP and its homologs where the N-
termini of these proteins may also act as ligands to stimulate
downstream pathways that modulate neurotransmission.
Supporting Information
File S1 Supplementary tables.
Found at: doi:10.1371/journal.pone.0012790.s001 (0.07 MB
DOC)
Figure S1 Molting defect seen during apl-1 RNAi. (A)
Representative pictures of the various molting defects seen in
RNAi sensitive strain rrf-3(pk1426) L4s during apl-1 knock-down.
Arrowheads point to regions described by the inlaid text. (Scale
Figure 7. Model for APL-1 transport and function. As a transmembrane protein, APL-1 moves through the endoplasmic reticulum (ER) and
Golgi followed by sorting into its appropriate vesicular population through the action of UNC-108. From there, proper APL-1 transport through the
neuron depends on the motor proteins UNC-104 or UNC-116. Once APL-1 reaches the plasma membrane (PM) it can be endocytosed and transported
to the early endosome through the action of RAB-5. APL-1 is then likely sent for degradation or recycled back to the plasma membrane. While APL-1
processing is unclear, release of the extracellular domain is necessary for survival and molting. Whether APL-1 is able to regulate neurotransmission at
the plasma membrane or at some point upstream has yet to be determined.
doi:10.1371/journal.pone.0012790.g007
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in worms on apl-1 RNAi after 48 hours from egg stage (n=173).
(C) Percentage of different progeny stages 48 hours from egg stage
on both control (L4440) and apl-1 RNAi.
Found at: doi:10.1371/journal.pone.0012790.s002 (1.06 MB TIF)
Figure S2 Rescue strains of apl-1 (tm385) have slower develop-
ment. (A) Map of apl-1(tm385) deletion and premature stop codon.
(B) Percentage of different larval stages after 48 hours of growth.
The N2 strain and heterozygous apl-1(tm385)/lon-2(e678) are
shown as negative controls. (N2, n=697; apl-1/lon-2, n=186; N2
Ex(apl-1::gfp)- 20 ng/ml, n=528). Missing worms were those
unaccounted for after 48 hours from the original total of eggs
placed on the plate. These are likely in large proportion part of the
L1 lethal population that are no longer visible. (C) No movement
defects were detected in the transgenic APL-1::GFP strain. (N2,
n=14; apl-1/lon-2, n=10; N2 Ex(apl-1::gfp)- 20 ng/ml, n=14). (D)
Brood sizes from the transgenic APL-1::GFP strain were normal
when compared to the N2 and apl-1/lon-2 strains. (N2, n=14; apl-
1/lon-2, n=11; N2 Ex(apl-1::gfp) - 20 ng/ml, n=14). (*, P,0.05;
**, P,0.01; ***, P,0.001.) Error bars represent the s.e.m.
Found at: doi:10.1371/journal.pone.0012790.s003 (0.64 MB TIF)
Figure S3 C-terminal GFP is not detrimental to the full length
APL-1 rescue. (A) qRT-PCR of rescue strains showing compar-
ative APL-1 expression with or without GFP. Error represents the
STD. (B) Aldicarb experiment showing the retained hypersensi-
tivity of full length APL-1 without the GFP tag at 10 ng/ml and
5 ng/ml. Error is the s.e.m.
Found at: doi:10.1371/journal.pone.0012790.s004 (0.28 MB TIF)
Figure S4 C-terminal mutation rescue strains cannot rescue the
aldicarb hypersensitivity. (A) Western blot showing protein
expression levels from the different rescue strains. (B) Rescue
strains with either a C-terminal truncation or deletion of the
YENPTY domain could not rescue the aldicarb hypersensitivity.
(C) Quantification of the aldicarb experiment at the 90 min time-
point. (*, P,0.05; **, P,0.01.) Error bars represent the s.e.m.
Found at: doi:10.1371/journal.pone.0012790.s005 (0.54 MB TIF)
Figure S5 Loss of kinesin-1 function also leads to a reduction in
APL-1::GFP fluorescence. (A) Representative pictures of head
neurons with apl-1::gfp expression on N2 and unc-116 backgrounds.
(Scale bar, 2.5 mm.) (B) Quantification of APL-1::GFP fluores-
cence (n=10 per strain). (*, P,0.05.) Error bars represent the
s.e.m.
Found at: doi:10.1371/journal.pone.0012790.s006 (0.41 MB TIF)
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